Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PIK3CD | O00329 | 6/20 | 0.38 |
| ▸ | HTR1A | P08908 | 8/20 | 0.35 |
| ▸ | CNR2 | P34972 | 1/20 | 0.34 |
| ▸ | HPGD | P15428 | 2/20 | 0.34 |
| ▸ | DRD2 | P14416 | 1/20 | 0.34 |
| ▸ | DRD4 | P21917 | 1/20 | 0.34 |
| ▸ | DRD3 | P35462 | 1/20 | 0.34 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.33 |
| ▸ | LRRK2 | Q5S007 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31268972 | 0.98 | PIK3CD (0.38) | PIK3CDHTR1ACNR2DRD2DRD4 | |
| SCHEMBL31269198 | 0.94 | PIK3CD (0.35) | PIK3CDHTR1ADRD2DRD4DRD3 | |
| SCHEMBL31269121 | 0.94 | PIK3CD (0.40) | PIK3CDHTR1ACNR2TSHRLRRK2 | |
| SCHEMBL31268886 | 0.94 | PIK3CD (0.40) | PIK3CDHTR1ADRD2DRD4DRD3 | |
| SCHEMBL31269199 | 0.94 | HPGD (0.40) | PIK3CDHTR1AHPGDLRRK2 | |
| SCHEMBL31269076 | 0.94 | PIK3CD (0.37) | PIK3CDHTR1ADRD2DRD4DRD3 | |
| SCHEMBL31268769 | 0.92 | PIK3CD (0.36) | PIK3CDLRRK2 | |
| SCHEMBL31269164 | 0.92 | PIK3CD (0.40) | PIK3CDHTR1ACNR2DRD2DRD4 | |
| SCHEMBL31269208 | 0.92 | PIK3CD (0.37) | PIK3CDHTR1ADRD2DRD4DRD3 | |
| SCHEMBL31269085 | 0.91 | PIK3CD (0.37) | PIK3CD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4689155-A1 | USE OF INHIBITORS TO INCREASE EFFICIENCY OF CRISPR/CAS INSERTIONS | Astrazeneca AB (SE) | 2026-02-11 | — | — | EP | disclosed |
| WO-2024201368-A1 | USE OF INHIBITORS TO INCREASE EFFICIENCY OF CRISPR/CAS INSERTIONS | ASTRAZENECA AB (SE) | 2024-10-03 | — | — | WO | disclosed |